@article{ref1,
title="Risperidone in the treatment of psychotic depression",
journal="Clinical neuropharmacology",
year="2000",
author="Miodownik, C. and Lerner, V.",
volume="23",
number="6",
pages="335-337",
abstract="Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.<p /><p>Language: en</p>",
language="en",
issn="0362-5664",
doi="10.1097/00002826-200011000-00007",
url="http://dx.doi.org/10.1097/00002826-200011000-00007"
}